Insulin resistance, a common feature of obesity and type 2 diabetes, leads to compensatory hyperinsulinemia, which may stimulate cellular proliferation by activating the insulin-like growth factor-1 (IGF-1) axis (38, 39). This evidence concerns the gene IGF1 and obesity disorder.